General Information of Drug (ID: DMU7RVH)

Drug Name
ASP7317
Indication
Disease Entry ICD 11 Status REF
Age-related macular degeneration 9B75.0 Phase 1 [1]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
D69KBS

References

1 ClinicalTrials.gov (NCT03178149) A Study of the Safety and Tolerability of ASP7317 in Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. U.S. National Institutes of Health.